Article
The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Nov 2007
Vollset Stein Emil, Igland Jannicke, Jenab Mazda, Fredriksen Ase, Meyer Klaus, Eussen Simone, Gjessing Håkon K, Ueland Per Magne, Pera Guillem, Sala Núria, Agudo Antonio, Capella Gabriel, Del Giudice Giuseppe, Palli Domenico, Boeing Heiner, Weikert Cornelia, Bueno-de-Mesquita H Bas, Carneiro Fátima, Pala Valeria, Vineis Paolo, Tumino Rosario, Panico Salvatore, Berglund Göran, Manjer Jonas, Stenling Roger, Hallmans Göran, Martínez Carmen, Dorronsoro Miren, Barricarte Aurelio, Navarro Carmen, Quirós José R, Allen Naomi, Key Timothy J, Bingham Sheila, Linseisen Jakob, Kaaks Rudolf, Overvad Kim, Tjønneland Anne, Büchner Frederike L, Peeters Petra H M, Numans Mattijs E, Clavel-Chapelon Françoise, Boutron-Ruault Marie-Christine, Trichopoulou Antonia, Lund Eiliv, Slimani Nadia, Ferrari Pietro, Riboli Elio, González Carlos A
Abstract excerpt
Previous studies have shown inconsistent associations of folate intake and polymorphisms of the methylenetetrahydrofolate reductase (MTHFR) gene with gastric cancer risk. Our nested case-control study within the European Prospective Investigation into Cancer and Nutrition cohort is the first prospective study of blood folate levels and gastric cancer. Gastric cancer cases (n=247) and controls (n=631) were matched...
Read the complete abstract on PubMed